AACR logo

More articles from Poster Discussion 1 - Multigene Prognostic Signatures

A BRCA1-Like, 25-Gene Assay Predicts for Anthracycline-Chemosensitivity in Sporadic Triple-Negative Breast Cancer.
A. Rodriguez, M. Rimawi, M. Wu, B. Dave, H. Wong, M. Landis, M. Cairo, A. Pavlick, A. Froehlich, G. Chamness, S. Hilsenbeck, M. Lewis, C. Osborne, J. Chang

Cancer Research Dec 2009, 69 (24 Supplement) 110; DOI: 10.1158/0008-5472.SABCS-09-110
Comparison of Prognostic Signatures in Node-Negative Tamoxifen-Treated Breast Cancer Patients.
V. Müller, M. Schmidt, A. Rody, K. Milde-Langosch, M. Kaufmann, H. Kölbl, F. Jänicke, K. Weber, M. Gehrmann

Cancer Research Dec 2009, 69 (24 Supplement) 104; DOI: 10.1158/0008-5472.SABCS-09-104
A Genomic-Profile Derived Summary Measure of Chromosomal Breakpoints Predicts Response to Treatment with the DNA-Damaging Agent Cisplatin.
N. Juul, Y. Wang, J. Kim, A. Eklund, Q. Li, V. Carlton, M. Gerlinger, C. Swanton, J. Garber, D. Silver, M. Faham, A. Richardson, Z. Szallasi, Z. Szallasi, Z. Wang

Cancer Research Dec 2009, 69 (24 Supplement) 111; DOI: 10.1158/0008-5472.SABCS-09-111
Evaluation of the Predictive Performance and Regimen Specificity of a 30-Gene Predictor of Pathologic Complete Response in a Prospective Randomized Neoadjuvant Clinical Trial for Stage I-III Breast Cancer.
A. Tabchy, W. Symmans, V. Valero, T. Vidaurre, A. Lluch, Y. Qi, E. Souchon, L. Barajas-Figueroa, H. Gomez, M. Martin, C. Coutant, K. Hess, G. Hortobagyi, L. Pusztai

Cancer Research Dec 2009, 69 (24 Supplement) 101; DOI: 10.1158/0008-5472.SABCS-09-101
Identification of a Prognostic Signature Based on the Expression of Insulin-Related Genes in Early Breast Cancer.
A. Gennari, M. Sormani, A. Decensi, A. Decensi, P. Pronzato, V. Mirisola, M. Puntoni, M. Roncella, M. Ghilli, P. Bruzzi, U. Pfeffer

Cancer Research Dec 2009, 69 (24 Supplement) 108; DOI: 10.1158/0008-5472.SABCS-09-108
A Meta-Analysis of Gene Expression Profiling Studies Identifies Clinically Relevant Oncogenic Pathways in Basal-Like Breast Cancer.
M. Ignatiadis, P. Bedard, B. Haibe-Kains, B. Haibe-Kains, S. Singhal, S. Loi, C. Criscitiello, C. Desmedt, G. Bontempi, M. Piccart, M. Piccart, C. Sotiriou, C. Sotiriou

Cancer Research Dec 2009, 69 (24 Supplement) 106; DOI: 10.1158/0008-5472.SABCS-09-106
Limited Clinical Utility of Prognostic Gene Expression Profiles in Grade 3 Node-Negative Early Stage Breast Cancer.
P. Bedard, M. Ignatiadis, B. Haibe-Kains, B. Haibe-Kains, S. Loi, C. Criscitiello, C. Desmedt, G. Bontempi, M. Piccart, M. Piccart, C. Sotiriou, C. Sotiriou

Cancer Research Dec 2009, 69 (24 Supplement) 103; DOI: 10.1158/0008-5472.SABCS-09-103
Prediction of 10-Year Chemotherapy Benefit and Breast Cancer-Specific Survival by the 21-Gene Recurrence Score (RS) Assay in Node-Positive, ER-Positive Breast Cancer – An Update of SWOG-8814 (INT0100).
K. Albain, W. Barlow, S. Shak, G. Hortobagyi, R. Livingston, I. Yeh, P. Ravdin, R. Bugarini, F. Baehner, N. Davidson, G. Sledge, E. Winer, C. Hudis, J. Ingle, E. Perez, K. Pritchard, L. Shepherd, J. Gralow, C. Yoshizawa, D. Allred, C. Osborne, D. Hayes, For The Breast Cancer Intergroup of North America

Cancer Research Dec 2009, 69 (24 Supplement) 112; DOI: 10.1158/0008-5472.SABCS-09-112
The M2/Alternatively Activated Macrophage Phenotype Correlates with Aggressive Histopathologic Features and Poor Clinical Outcome in Early Stage Breast Cancer.
G. Khramtsova, C. Liao, A. Khramtsov, S. Li, C. Gong, D. Huo, R. Nanda

Cancer Research Dec 2009, 69 (24 Supplement) 107; DOI: 10.1158/0008-5472.SABCS-09-107
Wnt Signaling Prognosticates Outcome in Breast Cancer Cohorts.
B. Barwick, K. Kerstann, M. Abramovitz, B. Leyland-Jones

Cancer Research Dec 2009, 69 (24 Supplement) 109; DOI: 10.1158/0008-5472.SABCS-09-109

Main menu

User menu

Search

More articles from Poster Discussion 1 - Multigene Prognostic Signatures

Pages

Articles

Info for

About Cancer Research